Professional Documents
Culture Documents
Introduction
Obesity is a chronic, progressive, and relapsing disease, defined as having a body mass index (BMI) 30kg/m2. The health risk associated with excess body fat can also be measured using waist circumference measurements. A measure of 102cm and 88cm in Caucasian, and 90cm and 80cm in Asian men and women respectively, indicate significant health risk. Over the past two decades the prevalence of obesity has trebled, with approximately a quarter of adults in the UK obese.1, 2 It is further predicted that 40 per cent of the population could be obese by 2025 and 60 per cent by 2050.3 Obesity is the primary aetiological factor in the development of many chronic diseases such as diabetes, hypertension, coronary heart disease (CHD) and cardiovascular disease (CVD)4, 5 and has a negative impact on patients quality of life.6 The treatment of obesity has huge implications for both public health and health service expenditure. The projected cost of obesity to the NHS could double to 10 billion a year by 2050. The wider cost to employers and the economy will be much greater and is estimated at approximately 50 billion at todays prices.3
Guidelines
Clinical guidelines for obesity in primary care have been published in the UK. The Scottish Intercollegiate Guidelines Network (SIGN) recently published their reviewed guidelines on the Management of Obesity.7 Most health boards and primary care trusts (PCTs) will have a well established National Service Framework (NSF) to manage CHD,8 and a delivery strategy for the diabetes NSF9 in which weight management is a component. In 2004, the Department of Health published its White Paper Choosing health (2004): Making healthy choices easier, providing commitments for action on obesity.10 The Scottish Government produced their own action plan Healthy Eating Active Living (HEAL) to improve diet, and increase physical activity.11 The National Institute for Clinical Excellence (NICE)12 produced the first national guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children in England and Wales. The aim of this guidance was to stem the rising prevalence of obesity and diseases associated with it, and increase the effectiveness of interventions to prevent overweight and obesity. It aims to improve the care provided to adults and children with obesity, particularly in primary care. These recommendations, like SIGN, are based on the best available evidence of effectiveness, including cost effectiveness and provide recommendations on the clinical management of overweight and obesity in both NHS and non NHS settings. The NICE guidelines support the implementation of the
Choosing Health White Paper in England,13 Designed for Life in Wales,14 the revised GP contract,15 and the existing NSFs. The clinical management of obesity cannot be viewed in isolation from the environment in which people live.12 A comprehensive and integrative primary care-led approach to weight management is possible, but needs a shift of resources, organisation, training and attitudes in order to maximise its potential impact.16 The 2004 Wanless Report Securing Good Health for the Whole Population17 also stressed that a substantial change will be needed to produce the reductions in preventable diseases such as obesity that will lead to the greatest reductions in future healthcare costs, recommending a more effective delivery framework for health services providers. The way in which general practice is reimbursed for patient care changed in 2004 with the renegotiation of the General Medical Services (GMS) contract, the Quality and Outcomes Framework (QOF). Practitioners aim to achieve points consequent to treating patients for particular conditions, which are weighted according to Government priority. Unfortunately, the treatment of obesity has not been recognised to a great degree within QOF, in which eight out of a total of 1000 points are awarded for an obesity register, and recording a BMI 30 kg/m2. In practice this provides little incentive for primary care to prioritise weight management delivery and achieve the aim of the NICE guideline to stem the rising prevalence of obesity and associated diseases. There are a further 177 QOF points, influenced by providing appropriate advice and treatment
Research
As part of a Continuous Improvement Programme, the Counterweight project team conducted a qualitative study to explore factors affecting programme implementation in practices that were successful and unsuccessful in the recruitment and follow up of patients in primary care. Successful practices had a general commitment from a wide range of practice staff especially GPs, when the programme was being established. There was also a committed and enthusiastic PN to take responsibility for the ongoing support and delivery of weight management in practice. The provision of training materials and patient education resources that were tailored to a structured weight management programme were seen as important to prevent the use of ad-hoc and often non evidence-based literature distribution. Successful practices were able to integrate structured weight management into practice routine. The barriers in practice were very much the competing priorities for practice time, low level of commitment from GPs, high turnover of staff, and scepticism about the likely success of obesity management in practice.24
Counterweight
The Counterweight weight management project was set up to determine to what extent measures of success could be achieved in routine primary care, with the primary outcome measures being weight change at 12 and 24 months. The SIGN guidelines7 were used to help create screening and treatment pathways for use by practice nurses for the management of their obese patients. Primary care nurses from 65 UK general practices delivered interventions to 1906 patients with BMI 30kg/m2 or BMI 28kg/m2 with an obesity related disease. The mean baseline weight was 101.2kg (BMI 37 kg/m2 ); 25 per cent of patients had a BMI 40kg/m2 and 74 per cent had 1 obesity related disease. 1419 patients were in the programme for 12 months. Mean weight change in those who attended and had data at 12 months was -3.0kg and at 24 months was -2.3kg. Among attenders 30.7 per cent had maintained a clinically significant weight loss of 5 per cent at 12 months, and 31.9 per cent at 24 months. The Counterweight weight management programme was able to evidence that clinically significant weight loss of 5 per cent and weight maintenance was achievable within routine primary care.22
Funding
The Scottish Government have further shown their commitment to their HEAL action plan by funding the Counterweight weight management programme. This is the only peer reviewed, evidence-based weight management programme to be made available and implemented throughout primary care in 13 of the 14 health board areas in Scotland from
Pharmaceutical aids
The only pharmaceutical aid currently available for the management of obesity is orlistat (Xenical [Roche pharmaceuticals] or Alli [GSK]) available over the counter. This drug is a Lipase enzymes inhibitor, which is not absorbed by the GI tract. This reduces the fat absorbed from the intestine, causing fat malabsorption. It is recommended that patients on these agents choose products that contain less than 3 per cent fat. If foods are higher in fat, the patient consequently experiences oily or fatty stools. It is recommended that these drugs are used as part of an overall pathway for the management of obesity in primary care, and as an adjunct to lifestyle changes made by the patient. It is not recommended that patients are prescribed these medications with no other support to make changes to their eating and activity levels.
Referral
Patients who have not achieved a 5 per cent or 5kg weight loss following an intervention programme of weight management, but are still motivated to make lifestyle changes should be referred to their local dietetic departments. Dietitians often have strict referral criteria, with the use of standard protocols for patients on weight management programmes, and are proficient in the use of behaviour change therapy. The Counterweight programme found that only 8 per cent of patients who were still in the programme for a year were referred on to a dietitian for further support.
Surgery
Patients referred for bariatric surgery are often done so via the secondary care obesity clinics, where these services are available. The NICE guidelines, however recommend that patients who have a BMI >50kg/m2 be referred directly for consideration for bariatric surgery services.12 In many regions, referral to bariatric surgical services remains ad-hoc, and demand often outstrips resources for these services.
Conclusion
It can be seen that the prevalence of obesity and consequent rise in obesity related diseases has both a profound affect on patients health and quality of life, but also on the treatment of this disease in primary care. It is important that PCTs and health board areas have an obesity strategy to allow appropriate referral of motivated patients through an organised pathway of evidence based treatments to the appropriate health professional for maximal impact.
Specialist Obesity Intervention (BMI 30/40+ plus obesity associated disease) Physician, Psychologist, Specialist Dietitian, Physiotherapist Decreasing patient numbers Decreasing resource/personnel available
References: 1. The NHS Information Centre, Lifestyle Statistics (2009). Statistics on obesity, physical activity and diet. Accessed online: http://www.ic.nhs.uk/webfiles/publications/opan09/OPAD%20Feb%202009%20final.pdf (Jan 2010). 2. The Scottish Health Survey (2008). Accessed online: http://www.scotland.gove.uk/Topics/Statistics/Browse/Health/scottish -heath-survey/Publications (Jan 2010). 3. The Foresight Report. Accessed online: www.foresight.gov.uk (Feb 2010). 4. Must A., et al. (1999). The disease burden associated with obesity. JAMA; 282: 1523-1529. 5. The Counterweight Project Team (2008). The Counterweight Programme. Prevalence of CVD risk factors by body mass index and the impact of 10% weight change. Obesity Research and Clinical Practice; 2: 15-27. 6. Lean M.E., Han T.S., & Seidell, J.C. (1999). Impairment of health and quality of life using new US federal guidelines for the identification of obesity. Arch Intern. Med.; 159: 837-843. 7. Scottish Intercollegiate Guidelines Network (SIGN) 2010. Management of Obesity. www.sign.ac.uk/pdf/sign115.pdf (Accessed online March 2010) 8. Department of Health (2000). Coronary heart disease: national service framework for coronary heart disease modern standards and service models. Accessed online: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH_4094275 (Feb 2010). 9. Department of Health (2001). National service framework for diabetes: standards. Accessed online: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4002951 (Feb 2010). 10. Department of Health (2004). Choosing health: Making healthier choices easier. London. 11. The Scottish Government (2008). Healthy Eating, Active Living: An action plan to improve diet, increase physical activity and tackle obesity (2008-2011). Edinburgh. 12. National Institute of Clinical Excellence (NICE) (2006). Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. Accessed online: http://www.nice.org.uk/nicemedia/pdf/CG43NICEGuideline.pdf (Feb 2010). 13. Department of Health 2004. Choosing Health: Making healthy choices easier. Accessed online: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4094550 (Feb 2010). 14. Welsh Assembly Government (2005). Designed for life: Creating world class Health and Social Care for Wales in the 21st Century. Accessed online: http://www.wales.nhs.uk/documents/designed-for-life-e.pdf (Feb 2010). 15. Department of Health (2003). Delivering Investment in General Practice. Implementing the new GMS contract. Accessed online: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4070231.pdf (Feb 2010). 16. Mercer SW., & Tessier S (2001). A qualitative study of general practitioners' and practice nurses' attitudes to obesity management in primary care. Department of General Practice, University of Glasgow. Health Bull (Edinb).; 59(4): 248-53. 17. Wanless Report (2004) Securing good health for the whole population. Accessed online: http://www.dh.gov.uk/en/Publicationsandstatistics/P ublications/PublicationsPolicyAndGuidance/DH_4074426 (Feb 2010). 18. Dr Foster (2005). Primary care management of adult obesity. London. 19. Hiddink, G.J., et al (1997). Consumers expectations about nutrition guidance: the importance of primary care physicians. Am J. Clin Nutr.; 65 (Suppl 6): 1974S-1979S. 20. House of Commons Select Committee (2004). Obesity. Third Report of Session 2003-04. London. The Stationery Office Ltd. 21. Pryke R, Docherty A (2008). Obesity in primary care: evidence for advising weight constancy rather than weight loss in unsuccessful dieters. British Journal of General Practice; 58: 112-117 22. The Counterweight Project Team (2008). Evaluation of the Counterweight programme for obesity management in primary care: a starting point for continuous improvement. The British Journal of General Practice; 58(553): 548-554. 23. Moore, H., et al. (2003) Improving the management of obesity in praimry care: cluster randomised trial. BMJ; 327: 1085-1088. 24. The Counterweight Project Team (2008). Engaging patients, clinicians and health funders in weight management: the Counterweight Programme. Family Practice.; 25(S1): I79-I86. 25. Rossner S, et al (2008). Long-term weight loss and weight-loss maintenance strategies. Obesity reviews; 9(6): 624-630. 26. Management of Obesity in Adults (2004): Project for European Primary Care: IJO.; 28: S226-231. 27. Haitman BL & Garby L (1999). Patterns of long term weight changes in overweight developing Danish men and women aged between 30 and 60 years. Int J Obes Relat Metab Disord.; 23: 1074-78. 28. Shaw K, et al (2006). Exercise for overweight or obesity. Cochrane Database Syst Rev.; 4: CD003817. 29. National Obesity Forum. Guidelines on Management of Adult Obesity and Overweight in Primary Care. Accessed online: www.nationalobesityforum.org/uk (Jan 2010). 30. Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEJM 346: 393-403. 31. Tuomilehto J, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with imparired glucose tolerance. NEJM.; 344: 1343-49. 32. Avenell A, et al (2004). Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess.; 8(21): iii-iv, 1-182.